Novogene Officially Launches Illumina Single-Cell 3’ RNA Sequencing Service

Sacramento, CA — [April1, 2026] — Novogene, a global leader in genomic services and solutions, today announced the official launch of its Illumina Single-Cell 3’ RNA Sequencing Service

As part of the launch, Novogene completed comprehensive internal benchmarking of the Illumina Fluent™ single-cell workflow across diverse biological sample types and capture scales. The evaluation demonstrated consistent gene detection, reliable cell recovery, and stable clustering performance, confirming the workflow’s robustness and reproducibility.

By optimizing laboratory and analytical procedures, Novogene delivers a practical single-cell solution designed to meet evolving research needs in immunology, oncology, neuroscience, and other translational and discovery-driven fields — all while maintaining affordability. By maintaining consistent technical standards across workflows, Novogene continues to support diverse research needs in the evolving single-cell landscape.

To learn more about the integrated Illumina Single-Cell workflow and technical specifications, visit our official service page

To celebrate the official launch, Novogene is also offering a limited-time promotional incentive. Details of the launch promotion are available on the official campaign page.